527
Participants
Start Date
December 3, 2020
Primary Completion Date
November 30, 2023
Study Completion Date
April 1, 2024
HIV-1 plasma RNA Genotyping secuencing by Sanger technique
After signing informed consent, we will collect whole blood for HIV genotyping in plasma HIV-1 RNA for testing of resistance-associated mutations to reverse transcriptase, protease, and integrase enzymes.
HIV-1 plasma RNA Genotyping secuencing by Ultra-deep sequencing technique
After signing informed consent, we will collect whole blood for HIV genotyping in plasma HIV-1 RNA for testing of resistance-associated mutations to reverse transcriptase, protease, and integrase enzymes.
REVIVA, Red de VIH del Valle del Cauca, Santiago de Cali
Collaborators (1)
ViiV Healthcare
INDUSTRY
Centro de Investigación en. Enfermedades Infecciosas, Mexico
OTHER_GOV
Fundacion REVIVA, Red de VIH del Valle del Cauca
NETWORK